TVGN
Tevogen Bio Holdings Inc.
7.30$
-7.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | +7.8% | -2.5% | +1.7% | +1.8% | – | – | +180.8% | -90.6% | +215.1% | -31.2% | +1.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.7% | +2,191.9% | -80.2% | -20.9% | -13.0% | +12.6% | -15.5% | +15.2% | -32.3% | +48.9% | +4.7% | – | |
| – | -22.7% | +832.6% | -48.6% | -36.9% | +133.2% | +8.7% | -61.7% | -4.6% | -4.4% | -9.5% | +5.0% | – | |
| – | -14.5% | +1,441.5% | -71.1% | -29.6% | +57.5% | +9.9% | -47.4% | +5.2% | -21.0% | +18.1% | +4.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.6% | -39.2% | -100.0% | +207,550.0% | +26.8% | +55.5% | +54.8% | +63.9% | +13.4% | +0.7% | +38.3% | – | |
| – | – | – | -185.8% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -107.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -153.7% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -183.0% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.